Pernicious Anemia

B12 Deficiency Across Pregnancy: A Continuous Exposure Timeline

by

Note: This outline is a work in progress. Most statements draw on the technical article in Reference 1; items marked “[ref needed]” indicate areas where I plan to add specific supporting studies in a later revision.

Core thesis: B12 deficiency creates a continuous risk window beginning before conception, extending through pregnancy and lactation, and surfacing months later in infants. Without recognition and treatment, this single deficiency causes neural tube defects, recurrent pregnancy loss, preeclampsia, gestational diabetes, infant neurologic crisis, and potentially permanent developmental and metabolic harm to both mother and child.1 Standard prenatal care—which universally supplements folic acid but rarely screens for B12—can mask the deficiency while neurologic damage progresses.1,2,3 Even when B12 supplementation occurs alongside folic acid, standard serum B12 testing cannot confirm adequate cellular uptake, as most circulating B12 is bound to metabolically inactive proteins rather than the transcobalamin required for tissue delivery.1

Read more

Pernicious Anemia and Subacute Combined Degeneration

by

Pernicious Anemia Is a Neurological Disease

I. Pernicious Anemia Is a Demyelinating Neurological Disease

Pernicious anemia (PA) is an autoimmune disorder in which vitamin B12 cannot be adequately absorbed or utilized, leading to progressive neurological injury.

Autoimmune failure of vitamin B12 absorption disrupts methylation and fatty acid metabolism essential for myelin maintenance and repair, producing central and peripheral demyelination, tract-specific spinal cord injury (classically subacute combined degeneration), and widespread cognitive, emotional, and psychiatric manifestations. These neurological effects frequently precede anemia and may occur in its absence.

Pernicious anemia (PA) typically has an insidious onset, with early symptoms that are nonspecific and easily misattributed. As a result, diagnosis is often delayed several years from symptom onset to receive a correct diagnosis, and a substantial proportion are initially misdiagnosed or not diagnosed at all. During this period, neurological injury continues to accumulate. Clinicians are therefore often faced with patients who already have advanced neural involvement by the time the underlying disorder is recognized.

Because myelin repair is metabolically demanding and time-dependent, outcomes depend not only on correcting cellular B12 deficiency but on interacting system constraints rather than hematologic markers alone.

Understanding how this injury unfolds, and why its effects vary so widely, requires looking beyond any single pathway.

Read more

Associated Conditions: The Bigger Picture (PA)

by

Many PA patients have additional conditions that contribute to ongoing symptoms. Fatigue, brain fog, and weakness often have multiple causes. This guide looks beyond B12 to explain how treating the bigger picture can bring clearer recovery and better outcomes. Why This Matters Pernicious anemia doesn’t occur in isolation. The same autoimmune processes that damage your … Read more

Multiple Autoimmune Mechanisms Beyond Classic Gastritis

by

Pernicious Anemia: Multiple Autoimmune Mechanisms Beyond Classic Gastritis

Breakthrough research reveals why 40–60% of pernicious anemia patients test negative for intrinsic factor antibodies yet still require lifelong B12 therapy. These discoveries identify multiple autoimmune mechanisms affecting B12 absorption and utilization—some involving autoimmune gastritis through non-antibody pathways, others targeting completely different parts of the B12 system. The findings fundamentally expand our understanding of pernicious anemia as a spectrum of autoimmune B12 disorders rather than a single gastric disease.

Recent molecular discoveries have identified anti-CD320 receptor autoantibodies as a major cause of “autoimmune B12 central deficiency,” where patients develop selective nervous system B12 deficiency despite normal serum levels. Combined with genetic studies revealing five risk loci and emerging understanding of T-cell–mediated gastric destruction, these findings reshape the clinical approach to antibody-negative cases. This research demonstrates that pernicious anemia encompasses diverse autoimmune mechanisms affecting multiple points in B12 metabolism, explaining both gastritis-related and non-gastritis forms of the condition.

Read more